Moxidectin for LF, Cote d'Ivoire (DOLF)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The purpose of this study is to determine whether moxidectin (Mox) will be more effective than ivermectin (IVM) when used in single-dose combination therapies for lymphatic filariasis (LF).
Epistemonikos ID: 1b593ba24a4fcdae56aeb1b86de80d41b22b27c0
First added on: May 07, 2024